Medication info
Glavis Tablet (Metformin Hydrochloride)

Glavis Tablet (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
International Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 200400304 · Notified 2004.05.28 · Insurance code 643700870

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dose should be determined individually based on the drug's efficacy and tolerability and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control, treatment with this drug must be initiated at a low dose. Administer 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When the dose is increased to 2000mg, it is usually divided into 2 doses per day, in the morning and evening. For doses exceeding 2000mg, administer in 3 divided doses with meals; up to a maximum of 2550mg per day may be administered. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess the response to this drug and identify the minimum effective dose. Measure blood glycated hemoglobin levels approximately every 3 months. The goal of treatment with this drug, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients previously controlled by diet alone, short-term treatment with this drug may be sufficient to achieve an adequate effect. This drug may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other symptoms that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this drug must be discontinued immediately.
Child dose
Children 10 years of age and older and adolescents who are still growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Measure blood glucose levels after one week and adjust the dose. Gastrointestinal adverse effects may be improved by gradually increasing the dose. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.

Ingredients

Manufacturer
International Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes with insufficient blood glucose control
View approved original text

This drug is used for patients with type 2 diabetes who have difficulty controlling their blood sugar with diet and exercise alone, particularly in overweight adults and children and adolescents. In adults, it may be used alone or in combination with other oral hypoglycemic agents or insulin, and it can also be used in children aged 10 and older, either alone or in combination with insulin. This drug helps control blood sugar and effectively improves diabetes management.

How to take

Adult dose

The dose should be determined individually based on the drug's efficacy and tolerability and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control, treatment with this drug must be initiated at a low dose. Administer 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When the dose is increased to 2000mg, it is usually divided into 2 doses per day, in the morning and evening. For doses exceeding 2000mg, administer in 3 divided doses with meals; up to a maximum of 2550mg per day may be administered. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess the response to this drug and identify the minimum effective dose. Measure blood glycated hemoglobin levels approximately every 3 months. The goal of treatment with this drug, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients previously controlled by diet alone, short-term treatment with this drug may be sufficient to achieve an adequate effect. This drug may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other symptoms that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be monitored closely every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this drug must be discontinued immediately.

Child dose

Children 10 years of age and older and adolescents who are still growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Measure blood glucose levels after one week and adjust the dose. Gastrointestinal adverse effects may be improved by gradually increasing the dose. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.

Precautions

This drug may cause severe lactic acidosis or hypoglycemia, so caution is required. It should not be administered to patients with moderate to severe renal impairment, dehydration, serious infections, heart failure, or acute myocardial infarction. Additionally, patients scheduled for examinations using iodinated contrast should stop this drug and restart only after kidney function is confirmed to be normal. It should not be used in patients with hypersensitivity to this drug or a history of type 1 diabetes or diabetic ketoacidosis. In cases of severe infections or traumatic systemic conditions, or patients scheduled for surgery, this drug should be temporarily discontinued and restarted after kidney function returns to normal. Caution is also needed for patients with poor nutritional status, liver dysfunction, lung function impairment, or excessive alcohol intake. During this medication, there is an increased risk of lactic acidosis and hypoglycemia with irregular meals, vigorous exercise, or taking interacting medications, so it should be administered cautiously. Lactic acidosis is a rare but very serious side effect; if symptoms such as muscle pain, shortness of breath, fatigue, or abdominal pain occur, consult a doctor immediately. Gastrointestinal symptoms such as diarrhea, nausea, and vomiting are common, and initially increasing the dose gradually or taking it with meals may alleviate symptoms. This drug is excreted through the kidneys, so regular kidney function tests are necessary, and it should be discontinued if kidney function declines. Alcohol consumption can affect lactic metabolism and increase the risk of lactic acidosis, so excessive drinking should be avoided while taking it. If blood glucose control is poor or if hypoglycemic symptoms appear, notify medical personnel immediately, especially in the elderly or frail patients. During pregnancy, this drug crosses the placenta; therefore, patients who are planning to become pregnant or are pregnant should consult their doctor before using it. For nursing mothers, this drug is excreted in breast milk, so careful consideration should be given to the decision to continue nursing or stop medication. Dosage adjustments should be made cautiously for children and the elderly, with regular monitoring required. In cases of overdose, blood dialysis may be effective, so seek medical attention immediately. This drug has many drug interactions, so if the patient is taking other medications, they must inform medical personnel.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • appetite loss
  • dyspepsia
  • constipation
  • abdominal pain
  • unpleasant metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver function abnormalities
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to prevent air and moisture from entering. The storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature. Storing it this way can help maintain the drug’s efficacy for a long time.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.